Promega Corporation

MEK Inhibitor U0126 Product Information

  • Instructions for Use of Product(s)
  • V1121

Literature # 9PIV112

MEK Inhibitor U0126 is a chemically synthesized organic compound that inhibits the kinase activity of MAP Kinase Kinase (MAPKK or MEK). It has been used in both in vivo and in vitro studies of MEK.

Printed in USA. Revised 10/07.

PDF Icon Complete Protocol PDF (66kb)

Prefer a different language?

Your country is set to Spain. Your language is set to español. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.